Bugworks Research, an India-based clinical-stage biopharmaceutical company, announced on Wednesday that it has named Dr Renu Swarup as a honorary member of the Global Advisory Board.
Dr Swarup has served as the secretary, Department of Biotechnology, Government of India and brings in over three decades of experience in the biotech sector. She has served as the founding managing director, Biotechnology Industry Research Assistance Council (BIRAC) and as a fellow of the National Academy of Sciences, India (NASI) and actively supported women scientists as a member of the prime minister's Scientific Advisory Committee's task force on women in science. Dr Swarup is a part of The Organization for Women in Science for the Developing World.
Dr Anand Anandkumar - CEO, Bugworks Research said, 'Bugworks is pleased to welcome Dr Renu Swarup as a member of its Global Advisory Board. Dr Swarup, an accomplished geneticist, was formerly the secretary, Department of Biotechnology, Ministry of Science & Technology, India. She was one of the key architects to formulate India's Biotechnology Vision and Strategy including the COVID-19 vaccine roll-out initiatives. Under her inspirational leadership, Biotechnology Industry Research Assistance Council (BIRAC) has ushered in a new wave of biotech SMEs and start-ups, of which Bugworks was an early benefactor. We look forward to working closely with Dr Swarup to help us reach our goal of enabling equitable global access to Bugworks' innovative products.'
Anixa Biosciences transfers breast cancer vaccine IND from Cleveland Clinic
Sanofi completes acquisition of Vicebio to expand respiratory vaccines portfolio
Valneva reports positive final Phase 2 results for Lyme disease vaccine VLA15
Lunai Bioworks receives first LOI to license next-generation immune cell therapy
BioNet receives positive opinion from EMA for VacPertagen marketing authorisation in EU
Anixa Biosciences secures U.S. Patent strengthening breast cancer vaccine IP into mid 2040s
PharmaJet® and EVA Pharma Partner to Scale Needle-free Polio Immunisation Across Egypt
Frontier IP portfolio company achieves breakthrough in livestock vaccine trials
GC Biopharma's Phase 2 clinical trial results for BARYTHRAX published in Vaccine
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses